期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
核苷转运作为肿瘤化疗靶点的研究 被引量:1
1
作者 甄永苏 薛玉川 +3 位作者 曹寿松 戚长菁 胡继兰 粟俭 《中国肿瘤》 CAS 1995年第5期27-27,共1页
关键词 肿瘤 药物疗法 核苷转运 化疗靶点
下载PDF
Screening of treatment targets for Alzheimer's disease from the molecular mechanisms of impairment by β-amyloid aggregation and tau hyperphosphorylation 被引量:3
2
作者 林炼峰 罗焕敏 《Neuroscience Bulletin》 SCIE CAS CSCD 2011年第1期53-60,共8页
β-Amyloid (Aβ) over-expression and tau hyperphosphorylation are considered to be the central events in the pathogenesis of Alzheimer's disease (AD).Studies on them may help elucidate the precise molecular patho... β-Amyloid (Aβ) over-expression and tau hyperphosphorylation are considered to be the central events in the pathogenesis of Alzheimer's disease (AD).Studies on them may help elucidate the precise molecular pathogenesis of AD.Until now,although tau protein and Aβ remain the foci of AD research,the etiopathogenesis of AD and effective drugs for AD treatment are still largely unsolved.The present review was mainly focused on the molecular mechanism of Aβ aggregation-related impairment and the pathways leading to tau hyperphosphorylation,based on which some promising therapeutic targets for AD were also proposed. 展开更多
关键词 Alzheimer's disease aggregation tau hyperphosphorylation treatment targets
原文传递
Genomic landscape of gastric cancer: molecular classification and potential targets 被引量:6
3
作者 Jiawei Guo Weiwei Yu +1 位作者 Hui Su Xiufeng Pang 《Science China(Life Sciences)》 SCIE CAS CSCD 2017年第2期126-137,共12页
Gastric cancer imposes a considerable health burden worldwide, and its mortality ranks as the second highest for all types of cancers. The limited knowledge of the molecular mechanisms underlying gastric cancer tumori... Gastric cancer imposes a considerable health burden worldwide, and its mortality ranks as the second highest for all types of cancers. The limited knowledge of the molecular mechanisms underlying gastric cancer tumorigenesis hinders the development of therapeutic strategies. However, ongoing collaborative sequencing efforts facilitate molecular classification and unveil the genomic landscape of gastric cancer. Several new drivers and tumorigenic pathways in gastric cancer, including chromatin remodeling genes, Rho A-related pathways, TP53 dysregulation, activation of receptor tyrosine kinases, stem cell pathways and abnormal DNA methylation, have been revealed. These newly identified genomic alterations await translation into clinical diagnosis and targeted therapies. Considering that loss-of-function mutations are intractable, synthetic lethality could be employed when discussing feasible therapeutic strategies. Although many challenges remain to be tackled, we are optimistic regarding improvements in the prognosis and treatment of gastric cancer in the near future. 展开更多
关键词 gastric cancer chromatin remodeling RHOA p53 receptor tyrosine kinase DNA methylation
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部